SEC FORM 4

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

BRIDGE-COOK JEREMY K

(Last)

(First)

(Middle)

LUMINEX CORPORATION

12212 TECHNOLOGY BOULEVARD

(Street)

AUSTIN

78727

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
LUMINEX CORP [ LMNX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	VP, Luminex Molecular Diagn

3. Date of Earliest Transaction (Month/Day/Year)
03/01/2007

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	03/01/2007		A		156	A	⁽¹⁾	156	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Employee Stock Option (right to buy)	$31.34	03/01/2007		A		502		⁽²⁾	01/05/2010	Common Stock	502	⁽³⁾	502	D
Employee Stock Option (right to buy)	$16.53	03/01/2007		A		266		⁽⁴⁾	09/02/2009	Common Stock	266	⁽⁵⁾	266	D
Employee Stock Option (right to buy)	$15.67	03/01/2007		A		835		⁽⁶⁾	09/04/2007	Common Stock	835	⁽⁷⁾	835	D
Employee Stock Option (right to buy)	$21.37	03/01/2007		A		992		⁽⁶⁾	12/04/2007	Common Stock	992	⁽⁸⁾	992	D
Employee Stock Option (right to buy)	$21.09	03/01/2007		A		440		⁽⁹⁾	05/20/2011	Common Stock	440	⁽¹⁰⁾	440	D
Employee Stock Option (right to buy)	$28.49	03/01/2007		A		514		⁽¹¹⁾	08/18/2010	Common Stock	514	⁽¹²⁾	514	D
Employee Stock Option (right to buy)	$25.65	03/01/2007		A		19,061		⁽¹³⁾	09/05/2011	Common Stock	19,061	⁽¹⁴⁾	19,061	D
Employee Stock Option (right to buy)	$18.52	03/01/2007		A		24		⁽¹⁵⁾	07/16/2008	Common Stock	24	⁽¹⁶⁾	24	D
Employee Stock Option (right to buy)	$28.49	03/01/2007		A		1,375		⁽¹⁵⁾	07/16/2008	Common Stock	1,375	⁽¹⁷⁾	1,375	D
Employee Stock Option (right to buy)	$23.51	03/01/2007		A		409		⁽¹⁸⁾	12/16/2008	Common Stock	409	⁽¹⁹⁾	409	D
Employee Stock Option (right to buy)	$22.8	03/01/2007		A		580		⁽⁶⁾	05/29/2007	Common Stock	580	⁽²⁰⁾	580	D
Employee Stock Option (right to buy)	$28.49	03/01/2007		A		1,865		⁽⁶⁾	05/29/2007	Common Stock	1,865	⁽²¹⁾	1,865	D
Employee Stock Option (right to buy)	$27.78	03/01/2007		A		575		⁽⁶⁾	01/31/2008	Common Stock	575	⁽²²⁾	575	D

Explanation of Responses:

1. Received in exchange for 2,600 shares of Tm Bioscience Corporation ("Tm") common stock in connection with merger of Tm with Luminex Corporation (the "Merger"). On the effective date of the Merger, each share of Tm's common stock was converted into the right to receive $0.06 shares of Luminex Corporation's common stock.

2. This option was 40% vested at grant date. The remaining shares will vest in 3 equal installments on 01/05/2008, 01/05/2009 and 01/05/2010.

3. Received in the Merger in exchange for an employee stock option to acquire 8,379 shares of Tm common stock for $2.20 per share.

4. This option was 40% vested at grant date. The remaining shares will vest in 3 equal installments on 09/02/2007, 09/02/2008 and 09/02/2009.

5. Received in the Merger in exchange for an employee stock option to acquire 4,439 shares of Tm common stock for $1.16 per share.

6. This option was 100% vested at grant date.

7. Received in the Merger in exchange for an employee stock option to acquire 13,924 shares of Tm common stock for $1.10 per share.

8. Received in the Merger in exchange for an employee stock option to acquire 16,540 shares of Tm common stock for $1.50 per share.

9. This option was 0% vested at grant date. The remaining shares will vest in 5 equal installments on 05/20/2007, 05/20/2008, 05/20/2009, 05/20/2010 and 05/20/2011.

10. Received in the Merger in exchange for an employee stock option to acquire 7,340 shares of Tm common stock for $1.48 per share.

11. This option was 20% vested at grant date. The remaining shares will vest in 4 equal installments on 08/18/2007, 08/18/2008, 08/18/2009 and 08/18/2010.

12. Received in the Merger in exchange for an employee stock option to acquire 8,567 shares of Tm common stock for $2.00 per share.

13. This option was 0% vested at grant date. The remaining shares will vest in 5 equal installments on 09/05/2007, 09/05/2008, 09/05/2009, 09/05/2010 and 09/05/2011.

14. Received in the Merger in exchange for an employee stock option to acquire 317,694 shares of Tm common stock for $1.80 per share.

15. This option was 60% vested at grant date. The remaining shares will vest in 2 equal installments on 07/16/2007 and 07/16/2008.

16. Received in the Merger in exchange for an employee stock option to acquire 408 shares of Tm common stock for $1.30 per share.

17. Received in the Merger in exchange for an employee stock option to acquire 22,920 shares of Tm common stock for $2.00 per share.

18. This option was 60% vested at grant date. The remaining shares will vest in 2 equal installments on 12/16/2007 and 12/16/2008.

19. Received in the Merger in exchange for an employee stock option to acquire 6,831 shares of Tm common stock for $1.65 per share.

20. Received in the Merger in exchange for an employee stock option to acquire 9,680 shares of Tm common stock for $1.60 per share.

21. Received in the Merger in exchange for an employee stock option to acquire 31,088 shares of Tm common stock for $2.00 per share.

22. Received in the Merger in exchange for an employee stock option to acquire 9,592 shares of Tm common stock for $1.95 per share.

Remarks:

	/S/ JEREMY K. BRIDGE-COOK	04/05/2007
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.